News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
How Pfizer (PFE) is Quietly Rebuilding Its Alzheimer's Pipeline     10/19/2016
All Eyes on Eli Lilly (LLY)'s Large-Scale Alzheimer's Trial     10/17/2016
A Look at This Tiny Massachusetts Biotech That Could Take Down Alzheimer's     10/11/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again     9/23/2016
Will Biogen (BIIB)’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?     9/20/2016
Eisai Company (ESALY.PK) Launches Ambitious 90-Scientist Collaborative R&D Unit in Boston Area     9/16/2016
NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial     9/7/2016
Biogen (BIIB)’s Shares Rise After FDA Fast Tracks Alzheimer’s Drug     9/2/2016
Biogen (BIIB)'s Experimental Alzheimer’s Drug Shows Promise in Human Trials     9/1/2016
Why Eli Lilly (LLY) Execs are Bullish About Its Alzheimer's Drug Solanezumab     8/23/2016
Eli Lilly (LLY)'s Incoming CEO May Carry First Alzheimer's Drug Across The Finish Line     8/22/2016
Anavex (AVXL) Plummeted on Phase IIa Alzheimer's Results "Considered" Positive     7/28/2016
TauRx Pharma's Much-Watched Alzheimer's Drug Flops in Trial     7/27/2016
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D     5/10/2016
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response     4/28/2016

News from Around the Web
University of Pennsylvania Psychiatrist Questions Whether Antidepressants Prevent Alzheimer's     10/10/2016
Genetic Score Predicts Age-Related Risk Of Alzheimer's Disease, University of California, San Diego (UCSD) Study Says     10/5/2016
Eli Lilly (LLY)'s Alzheimer's Drug Could Potentially Bring in Billions     9/28/2016
Getting Real About An Alzheimer's Cure     9/9/2016
Lancaster University Scientists Link Air Pollution To Alzheimer's     9/6/2016
Shark Fins And Meat Contain High Levels Of Neurotoxins Linked To Alzheimer's, University of Miami Study Reveals     8/30/2016
Use It Or Lose It: Stopping Exercise Decreases Brain Blood Flow, University of Maryland Study Shows     8/30/2016
Gene Wilder Died Of Alzheimer’s. His Family Explains Why They Didn’t Disclose His Diagnosis     8/30/2016
This Helmet Shows What's Going On Inside A Person's Brain, Department of Energy Study     8/23/2016
Diet And Exercise Could Stop Alzheimer's From Forming, UCLA Study     8/17/2016
Treatment Option For Alzheimer’s Disease Possible, University of Manchester Study     8/15/2016
New Biochip-Based Blood Test Detects Elevated Risk for Alzheimer's Disease, Randox Reveals     8/4/2016
Deep Brain Stimulation for Early Alzheimer's? Toronto Western Hospital Study     7/29/2016
How Your Sight And Smell Could Be The Key For Early Detection Of Alzheimer's, Studies Reported at AAIC 2016 Reveal     7/27/2016
These Kinds Of Jobs Can Help Protect Your Brain From Alzheimer's, University of Wisconsin-Madison Study     7/26/2016

Press Releases
Human Metabolome Technologies Begins New Contract With National Institute on Aging, NIH To Study Brain Metabolomic Profiles In Alzheimer's Disease     10/21/2016
Bracket Announces New Study For Assessment Of Brain Insulin Resistance In Alzheimer's Disease     10/19/2016
C2N Completes Phase I Clinical Study Of C2N-8E12 (ABBV-8E12) Among Individuals With Progressive Supranuclear Palsy     10/13/2016
Recombinetics Awarded Two NIH Grants To Develop Humanized Swine Models Of Alzheimer's Disease And Neurofibromatosis 2     10/13/2016
ProMis Neurosciences Issues White Paper Entitled: Critical Insight - Toxic Soluble Amyloid Beta Oligomers ("Prions"), Not Plaque, Drive Pathogenesis In Alzheimer's Disease     10/4/2016
Neurim Pharmaceuticals Announces First Patients' Enrollments In ReCOGNITION - Phase II Clinical Trial Of Piromelatine For Mild Alzheimer's Disease     9/28/2016
EIP Pharma Announces Issuance Of Multiple New Patents Covering VX-745, A Selective P38 MAP Kinase Alpha Inhibitor For Alzheimer's Disease And Ischemic Stroke Recovery     9/28/2016
Human Microbiology Institute Release: New Research Indicates Alzheimer's and Other Neurodegenerative Diseases Are Contagious     9/23/2016
Allergan (AGN) And Adamas Pharma (ADMS) Announce U.S. Availability Of New Dosage Strengths For NAMZARIC (Memantine And Donepezil Hydrochlorides) Extended Release For The Treatment Of Moderate To Severe Alzheimer's Disease     9/22/2016
Transdermal Delivery Solutions & Alzyn Announce License For HypoSpray Delivery Of Alzheimers Therapy     9/20/2016
Ready, Set, Go! Cerebain Biotech Begins Development of Alzheimer's Medical Device     9/14/2016
ProMis Neurosciences Announces Positive Validation Of Novel Antibody Therapeutic Candidates For Alzheimer's Disease     9/13/2016
Cerebain Biotech Presents Update On Its Medical Device Research And Development As It Continues Its Battle Against Alzheimer’s And Dementia     9/13/2016
vTv Therapeutics (VTVT) Completes Enrollment Of Part A Of Pivotal Phase III Trial Evaluating Azeliragon For The Treatment Of Patients With Mild Alzheimer’s Disease     9/7/2016
Proclara Announces Initiation Of Phase Ib Clinical Trial Of NPT088 For Alzheimer’s Disease     9/7/2016